Time to stop reporting estimates of any prostate cancer risk with percentage of free prostate-specific antigen

Am J Clin Pathol. 2024 Jan 4;161(1):1-3. doi: 10.1093/ajcp/aqad109.
No abstract available

Keywords: PSA; antigen; cancer; free; overdiagnosis; overtreatment; prostate; risk; specific.

MeSH terms

  • Biomarkers, Tumor
  • Early Detection of Cancer
  • Humans
  • Male
  • Prostate-Specific Antigen*
  • Prostatic Neoplasms*


  • Prostate-Specific Antigen
  • Biomarkers, Tumor